Breaking News
eThalED Webinar Series: Liver Disease & Thalassaemia
IMR-687 Receives FDA Fast Track & Rare Pediatric Disease Designations for the Treatment of β-Τhalassaemia
Coronavirus Pandemic: How Close Are We to a Vaccine?
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF Publishes its Annual Report for 2019
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
Novartis sickle cell drug Adakveo put on path to EU approval
”Liver Disease & Thalassaemia”: En route to the 3rd TIF Webinar for Medical Specialists
WORLD HEPATITIS DAY 2020: Towards a ”Hepatitis-free Future”
THOUGHTS ABOUT ME AND MY DAUGHTER by Melissa Basberber
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country work
Projects
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
Liver Disease
Liver Disease
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
News
3 weeks ago
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
On the occasion of today´s World Hepatitis Day and with the aim of informing and raising awareness among patients with thalassaemia – and not only – about viral hepatitis that…
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Find out more
Okay, thanks
